Literature DB >> 21767193

Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.

Sara Thörnqvist1, Lise Bentzen, Jørgen B B Petersen, Liv B Hysing, Ludvig P Muren.   

Abstract

BACKGROUND AND
PURPOSE: Uncorrelated motion of targets and large deformations of organs at risk represent challenges for image-guidance in simultaneous integrated boost (SIB) radiotherapy (RT) of pelvic tumour sites. This study aims to evaluate the robustness towards geometrical uncertainties in prostate cancer using two image-guided RT (IGRT) set-up strategies for two SIB delivery methods. Secondly, we evaluate the ability of geometrical parameters to predict when the applied margins are insufficient, resulting in target underdosage (TUD).
MATERIAL AND METHODS: The study included nine patients with eight to nine repeat computed tomography (CT)-scans evenly distributed throughout their treatment course. The prostate target (CTV-p) and the lymph node target including seminal vesicles (CTV-ln/sv) were delineated in all scans. SIB treatment plans for intensity-modulated RT and volumetric modulated arc therapy were generated on the planning CT and transferred to the repeat CTs for dose re-calculation using registration based on either anatomy or intra-prostatic fiducial markers. Receiving operator characteristic analysis was used to deduce the ability of the parameters to predict TUD.
RESULTS: The dosimetric differences between the two positioning strategies were small for all parameters evaluated and significant only for the dose to rectum. Anatomy based registration resulted in inferior target coverage with a larger number of TUDs, mostly seen in the seminal vesicles. For both targets the highest sensitivity and specificity of predicting TUD was seen for the relative volume and the lowest was found for the displacement vector.
CONCLUSIONS: Positioning based on fiducials gave the best trade-off between coverage of the targets although resulting in the highest dose to rectum. Target underdosage occurred mostly in the seminal vesicles. For both targets, the best parameter to predict TUD was the relative volume.

Entities:  

Mesh:

Year:  2011        PMID: 21767193     DOI: 10.3109/0284186X.2011.590522

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.

Authors:  Maria Thor; Aditya Apte; Joseph O Deasy; Ludvig Paul Muren
Journal:  Acta Oncol       Date:  2012-12-04       Impact factor: 4.089

2.  Robust contour propagation using deep learning and image registration for online adaptive proton therapy of prostate cancer.

Authors:  Mohamed S Elmahdy; Thyrza Jagt; Roel Th Zinkstok; Yuchuan Qiao; Rahil Shahzad; Hessam Sokooti; Sahar Yousefi; Luca Incrocci; C A M Marijnen; Mischa Hoogeman; Marius Staring
Journal:  Med Phys       Date:  2019-07-12       Impact factor: 4.071

3.  Evaluation of an a priori scatter correction algorithm for cone-beam computed tomography based range and dose calculations in proton therapy.

Authors:  Andreas Gravgaard Andersen; Yang-Kyun Park; Ulrik Vindelev Elstrøm; Jørgen Breede Baltzer Petersen; Gregory C Sharp; Brian Winey; Lei Dong; Ludvig Paul Muren
Journal:  Phys Imaging Radiat Oncol       Date:  2020-10-27

4.  Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT).

Authors:  Lisa Durrant; Maxwell Robinson; Maria A Hawkins; Frank Van den Heuvel; Rebecca Muirhead
Journal:  Radiother Oncol       Date:  2016-08-28       Impact factor: 6.280

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.